Groowe Groowe / Newsroom / PFE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PFE News

Pfizer Inc.

Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode

globenewswire.com
LLY NTHI OLMA PFE

Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

businesswire.com
PFE

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

businesswire.com
PFE

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

businesswire.com
PFE

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

prnewswire.com
PFE

Global Times: China’s 15th Five-Year Plan ushers in new chapter for Africa partnership: AU envoy

globenewswire.com
TSLA NVDA HPE IBM GOOG MSFT AMZN INTC AMD MU QCOM AAPL PFE MRK JNJ LLY BMY

Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants

globenewswire.com
PFE TARS TNXP

Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
KURA BMY IPHA MRK MNPR JAZZ MOLN LLY GSK AGEN PFE

Idea Grove Publishes Trust Signals® B2B Brand Rankings Across 16 Technology and Industrial Sectors

globenewswire.com
IBM ORCL MSFT GOOG NVDA AMAT INTC AMD SMCI CRM ADSK HON GE ETN ROK LIN AIR BA CAT DE TDG LMT RTX GD AVAV AEIS AMZN ACN WDC SE NOW MCHP ADI TXN QCOM MU PLTR SNOW DDOG PANW FTNT CRWD ZS VRSN PAYX PYPL AFRM UPST COIN MELI ETSY EBAY CVS MRVL LRCX KLAC ASML TER NXPI ON ALGN DXCM ISRG TNDM GOOGL META NFLX DIS CMCSA VZ T TMUS LUMN CSCO QGEN GILD AMGN BIIB REGN AZN PFE JNJ MRK BMY ABBV LLY XRAY COO CPRT CHKP NTAP VRTX MDT EW BMRN ALNY EXPE BKNG MAR HRL KHC PEP KO MCD SBUX YUM NDSN TTWO EA SRPT CRSP EDIT NTLA BNTX ACGL CB ALL TRV AXS PRGS JBHT CHRW ODFL UPS FDX XPO STLD NUE AA CF LYB DD EMR RIVN LCID NIO TSLA F GM STX HPQ DELL HPE ACEL APTV PTC AVB PLD AMH EQIX CCI AMT SBAC GLW FFIV AKAM NTES BILI PDD JD BABA BIDU

Brepocitinib Interest Gains Momentum in Idiopathic Inflammatory Myopathies as Rheumatologists Signal Readiness for Targeted, Steroid-Sparing Therapies

globenewswire.com
AZN PFE